{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:00:53Z","timestamp":1778626853258,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010677","name":"H2020 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejca.2019.07.003","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T22:47:13Z","timestamp":1567550833000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion"],"prefix":"10.1016","volume":"120","author":[{"given":"Ana","family":"Lluch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana M.","family":"Gonz\u00e1lez-Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3986-2084","authenticated-orcid":false,"given":"David","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agda K.","family":"Eterovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Mart\u00ednez de Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Guerrero-Zotano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ignacio","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Blancas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"L\u00f3pez-Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosal\u00eda","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleix","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Gonzalez-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Meric-Bernstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Albanell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejca.2019.07.003_bib1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2010.33.8889","article-title":"Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors","volume":"30","author":"Niikura","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2019.07.003_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-013-2825-2","article-title":"Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study","volume":"143","author":"De Due\u00f1as","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.ejca.2019.07.003_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","article-title":"A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases","volume":"50","author":"Aurilio","year":"2014","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2019.07.003_bib4","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1158\/0008-5472.CAN-16-2717","article-title":"Intrinsic subtypes and gene expression profiles in primary and metastatic breast cancer","volume":"77","author":"Cejalvo","year":"2017","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ejca.2019.07.003_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1158\/1535-7163.MCT-10-1089","article-title":"PI3K pathway mutations and PTEN levels in primary and metastatic breast cancer","volume":"10","author":"Gonzalez-Angulo","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"10.1016\/j.ejca.2019.07.003_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/1078-0432.CCR-10-1133","article-title":"PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer","volume":"17","author":"Jensen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2019.07.003_bib7","doi-asserted-by":"crossref","first-page":"11479","DOI":"10.1038\/ncomms11479","article-title":"The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes","volume":"7","author":"Pereira","year":"2016","journal-title":"Nat Commun"},{"issue":"7418","key":"10.1016\/j.ejca.2019.07.003_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejca.2019.07.003_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2019.07.003_bib10","series-title":"San Antonio Breast Cancer Symp. San Antonio, TX (USA)","article-title":"Mutational processes, genome evolution and outcome in metastatic breast cancers","author":"Patsouris","year":"2017"},{"issue":"6","key":"10.1016\/j.ejca.2019.07.003_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ejca.2019.07.003_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002201","article-title":"Mutational profile of metastatic breast cancers: a retrospective analysis","volume":"13","author":"Lefebvre","year":"2016","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ejca.2019.07.003_bib13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"issue":"7291","key":"10.1016\/j.ejca.2019.07.003_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nature08989","article-title":"Genome remodelling in a basal-like breast cancer metastasis and xenograft","volume":"464","author":"Ding","year":"2010","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ejca.2019.07.003_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002204","article-title":"The subclonal architecture of metastatic breast cancer: results from a prospective community-based rapid autopsy program \u201cCASCADE\u201d","volume":"13","author":"Savas","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejca.2019.07.003_bib16","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1038\/ncomms9760","article-title":"Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer","volume":"6","author":"Murtaza","year":"2015","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ejca.2019.07.003_bib17","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1158\/2159-8290.CD-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1016\/j.ejca.2019.07.003_bib18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/ng.3391","article-title":"In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer","volume":"47","author":"Janiszewska","year":"2015","journal-title":"Nat Genet"},{"issue":"7403","key":"10.1016\/j.ejca.2019.07.003_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","article-title":"The clonal and mutational evolution spectrum of primary triple-negative breast cancers","volume":"486","author":"Shah","year":"2012","journal-title":"Nature"},{"issue":"7520","key":"10.1016\/j.ejca.2019.07.003_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature13556","article-title":"Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity","volume":"514","author":"Marusyk","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2019.07.003_bib21","doi-asserted-by":"crossref","first-page":"14944","DOI":"10.1038\/ncomms14944","article-title":"Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations","volume":"8","author":"Brown","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2019.07.003_bib22","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.1017","article-title":"Genomic alterations driving breast cancer (BC) metastases and their relationship with the subtype switch in the GEICAM ConvertHER study","volume":"35","author":"Albanell","year":"2017","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2019.07.003_bib23","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"},{"issue":"5","key":"10.1016\/j.ejca.2019.07.003_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1158\/1535-7163.MCT-13-0482","article-title":"Concordance of genomic alterations between primary and recurrent breast cancer","volume":"13","author":"Meric-Bernstam","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"14","key":"10.1016\/j.ejca.2019.07.003_bib25","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.ejca.2019.07.003_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.ejca.2019.07.003_bib27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/bioinformatics\/btt771","article-title":"Bias from removing read duplication in ultra-deep sequencing experiments","volume":"30","author":"Zhou","year":"2014","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.ejca.2019.07.003_bib28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1593\/neo.111252","article-title":"Detection of somatic copy number alterations in cancer using targeted exome capture sequencing","volume":"13","author":"Lonigro","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.ejca.2019.07.003_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (catalogue of somatic mutations in cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.ejca.2019.07.003_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ccell.2015.02.007","article-title":"In silico prescription of anticancer drugs to cohorts of 28 tumor types reveals targeting opportunities","volume":"27","author":"Rubio-Perez","year":"2015","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.ejca.2019.07.003_bib31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nmeth.2642","article-title":"IntOGen-mutations identifies cancer drivers across tumor types","volume":"10","author":"Gonzalez-Perez","year":"2013","journal-title":"Nat Methods"},{"issue":"9","key":"10.1016\/j.ejca.2019.07.003_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMra1204892","article-title":"The implications of clonal genome evolution for cancer medicine","volume":"368","author":"Aparicio","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.07.003_bib33","series-title":"San Antonio Breast Cancer Symp. San Antonio, TX (USA)","article-title":"Evolutionary history and genomic landscape of metastatic breast cancer","author":"Paul","year":"2017"},{"issue":"12","key":"10.1016\/j.ejca.2019.07.003_bib34","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Genet"},{"issue":"21","key":"10.1016\/j.ejca.2019.07.003_bib35","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2019.07.003_bib36","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ajpath.2017.04.022","article-title":"Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters","volume":"187","author":"Russnes","year":"2017","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.ejca.2019.07.003_bib37","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/annonc\/mdw286","article-title":"Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers","volume":"27","author":"Fumagalli","year":"2016","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2019.07.003_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2019.07.003_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume":"10","author":"Tamborero","year":"2018","journal-title":"Genome Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919304034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919304034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:25:09Z","timestamp":1760732709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919304034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":39,"alternative-id":["S0959804919304034"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.07.003","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}